• 产品
  • 供应商
  • CAS号
  • 采购
  • 资讯
  • 会议
下载CPhI制药通APP

下载CPhI制药通APP

您的位置:首页 >> 制药产品大全 >> 原料药 >> 消化系统用药 >> Esomeprazole sodium API (under development)

Esomeprazole sodium API (under development)

Esomeprazole sodium API (under development)

更新时间:2018-04-16
CAS号:161796-78-7
药典:中国药典,企业标准
级别:Medicine Grade
详细描述
  • 主要销售市场:北美洲,中/南美洲,西欧,东欧,亚洲,中东,非洲
  • 提供样品:

Esomeprazole sodium API (under development)CAS号:161796-78-7

Esomeprazole sodium API (under development)分子式: C34H36MgN6O6S2

161796-78-7

Esomeprazole sodium API (under development)英文名称: Esomeprazole sodium

Esomeprazole sodium API (under development)英文同义词: 1H-BENZIMIDAZOLE, 5-METHOXY-2-[[(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-, SODIUM SALT; Esomeprazoleandsalts; 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-1H-benzimidazole sodium salt; sodium 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide; sodium 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-2,3-dihydrobenzimidazol-1-ide; bis[5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-yl]magnesium

Esomeprazole sodium API (under development)分子量: 713.1212

产品描述:

Category: API

Usage: It is used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome.

Applications: Pharmaceutical raw materials

Place of Origin: China

Quality Specification: Please contact Baiyu for updated version COA

 成立年份:2005

业务类型:制造商,出口商

主要销售市场:北美洲,中/南美洲,西欧,东欧,亚洲,中东,非洲

员工总人数:500以上

总资产(USD):不愿意公开

年销售额(USD):100,000,000至249,999,999

快速询盘
消化系统用药
CPhI制药在线为您找到Esomeprazole sodium API (under development)价格、Esomeprazole sodium API (under development)详细参数、Esomeprazole sodium API (under development)相关产品、Esomeprazole sodium API (under development)供应商等信息,想了解当前Esomeprazole sodium API (under development)最新报价,请联系成都百裕制药股份有限公司
CPhI 网上贸易平台: CPhI.cn| En-CPhI.cn| CPhI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00) 点击这里给我发消息 点击这里给我发消息